HemCon Receives CE Marking for ChitoFlex Hemorrhage Control Bandage.Certification Will Allow Expanded Presence into International Markets PORTLAND, Ore. -- HemCon Medical Technologies, Inc. has received the European Union European Union (EU), name given since the ratification (Nov., 1993) of the Treaty of European Union, or Maastricht Treaty, to the European Community CE marking for its unique hemorrhage hemorrhage (hĕm`ərĭj), escape of blood from the circulation (arteries, veins, capillaries) to the internal or external tissues. The term is usually applied to a loss of blood that is copious enough to threaten health or life. control ChitoFlex bandage bandage /ban·dage/ (ban´daj) 1. a strip or roll of gauze or other material for wrapping or binding a body part. 2. to cover by wrapping with such material. . With receipt of this certification, HemCon is positioned to increase distribution into countries requiring the CE marking including: Great Britain Great Britain, officially United Kingdom of Great Britain and Northern Ireland, constitutional monarchy (2005 est. pop. 60,441,000), 94,226 sq mi (244,044 sq km), on the British Isles, off W Europe. The country is often referred to simply as Britain. , Germany and the rest of the EU. The ChitoFlex bandage uses the same materials and technology as the HemCon hemorrhage control bandage that has been documented to have helped save over 100 lives in Iraq and Afghanistan. ChitoFlex is a 3" x 28" strip of flexible chitosan that is designed to be stuffed into wounds that cannot be addressed by conventional methods. "ChitoFlex was conceived and introduced in response to requests by the U.S. Military. It has already proven safe and effective in controlling severe battlefield hemorrhage." stated HemCon, Inc. President and Chief Executive Officer John W. Morgan John W. Morgan, BSc, LLB, MBA (born May 7, 1964), is a Canadian Lawyer, politician, and businessman. He is the current mayor of the Cape Breton Regional Municipality in Nova Scotia, Canada. . "This product is the platform for many new applications in civilian markets. The CE mark will now allow us to bring this life saving product to the international community." About HemCon Medical Technologies, Inc. HemCon Medical Technologies, Inc., founded in 2001, develops, manufactures, and markets innovative technologies to control bleeding and infection resulting from trauma or surgery. HemCon products are designed for use by military and civilian first responders as well as medical professionals in hospital, dental and clinical settings where rapid control of bleeding is of critical importance. The HemCon([R]) Bandage was developed in collaboration with the Oregon Medical Laser Center and Providence St. Vincent's Hospital Hospital:
|
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion